Resources | News - FRONTEO USA

「News」のResources一覧

Jun 30, 2026

Masahiro Morimoto, President & CEO of FRONTEO, Delivers a Lecture at American University in Washington, D.C.

Highlights the Value of Human-Centered AI and the Competitive Advantage of “KIBIT” in Supporting Scientific Discovery

Jun 2, 2026

Morimoto, CEO, Delivers Special Lecture at “Growth Strategy for Healthcare Annual Forum 2026,” Attended by Nobel Laureates, Ministers, and 500 CEOs, Leaders from Industry, Academia, and Government

May 28, 2026

FRONTEO and SCOHIA PHARMA Sign Agreement to Explore New Indications Using the AI Drug Discovery Support Service “DDAIF”

May 13, 2026

The University of Oklahoma confirms inhibition of cell proliferation with a novel candidate target molecule for pancreatic cancer discovered by FRONTEO's AI drug discovery support service, Drug Discovery AI Factory

Aiming to develop drugs that meet unmet medical needs by advancing to animal testing in the future

May 13, 2026

FRONTEO Opens KIBIT AI Biology Lab, a Center for AI Drug Discovery

Major update of the AI drug discovery support service Drug Discovery AI Factory and full-scale operation of the system that handles the upstream of the drug discovery value chain

Apr 23, 2026

Genenet Implements FRONTEO’s Medical Paper Search AI System “KIBIT Amanogawa” to Identify Anti-Aging Compounds in Industrial Waste and Plants

Trial Utilizing Fukuoka Prefecture Subsidy Program Yields Positive Results

Apr 16, 2026

FRONTEO and Astellas Pharma Sign Agreement for Target Molecule Discovery

“Drug Discovery AI Factory,” AI-based drug discovery support service, enables discontinuous discovery of new target molecules, paving the way for the early creation of innovative pharmaceuticals

Mar 31, 2026

FRONTEO and Keio University School of Medicine Have Been Granted Two Patents for a Conversational AI Program to Support Depression Diagnosis

The system assesses depressive symptoms based on approximately 10 minutes of free conversation; designed for use in a variety of medical and healthcare settings, including telemedicine and health screenings, it aims to address the treatment gap.

“TalkLab KIBIT,” a web application that uses AI analysis to assess “Brain Health Score” through conversation, has launched as part of Asahi Life's “Everyone's Peace of Mind 100-Year Project.”のサムネイル

Mar 26, 2026

TalkLab KIBIT,” a web application that uses AI analysis to assess “Brain Health Score” through conversation, has launched as part of Asahi Life Insurance's “Everyone's Peace of Mind 100-Year Project.”

Mar 5, 2026

FRONTEO Expands Reach of “Brain Health Score” Through Local Government Partnerships; Offers Hands-On Experience with “TalkLab KIBIT” in Gamagori City

Feb 18, 2026

FRONTEO and Nippon Kayaku Launch Co-creation Project Aimed at Maximizing the Value of Nippon Kayaku’s Drug Discovery Assets

By utilizing the “Drug Discovery AI Factory”—which discontinuously and systematically identifies previously unknown associations between diseases and target molecules based on existing literature—the companies aim to maximize the value of Nippon Kayaku’s drug discovery assets.

Feb 12, 2026

FRONTEO Launches “DDAIF Innovation Bridge” to Provide Scientific Support for Bio-Ventures Through Its AI-Driven Drug Discovery Support Service “Drug Discovery AI Factory”

1 2